FDA
-
-
-
-
-
-
-
Inozyme Pharma Reports Third Quarter 2024 Financial Results and Provides Business Highlights
-
-
-
-
-
-
-
Inozyme Pharma Presents New Data at the American Society for Bone and Mineral Research (ASBMR) 2024 Annual Meeting
-
-
-
-
-
-
-
Inozyme Pharma Reports First Quarter 2024 Financial Results and Provides Business Highlights
-
-
-
-
-
-
-
Inozyme Pharma Reports Third Quarter 2023 Financial Results and Provides Business Highlights
-
-
-
-
-
-
-
Inozyme Pharma Reports Second Quarter 2023 Financial Results and Provides Business Highlights
-
-
-
-
-
-
-
Inozyme Pharma (INZY) Reports Positive Topline Data from Ongoing Phase 1/2 Trials of INZ-701
-
-
-
-
-
-
-
Inozyme Pharma Secures Flexible Debt Facility for up to $70 Million with K2 HealthVentures
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

